Neil Chatterji
Stock Analyst at B. Riley Securities
(1.81)
# 3,397
Out of 5,182 analysts
21
Total ratings
38.89%
Success rate
4.34%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $18 → $20 | $11.21 | +78.41% | 6 | Mar 18, 2026 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $6.41 | +102.81% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $65.47 | -23.63% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.44 | +1,586.91% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $24.58 | -26.77% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $4.06 | +10.84% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.30 | +169.23% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $1.93 | +184.97% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $5.48 | +73.36% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Mar 18, 2026
Maintains: Buy
Price Target: $18 → $20
Current: $11.21
Upside: +78.41%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $6.41
Upside: +102.81%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $65.47
Upside: -23.63%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.44
Upside: +1,586.91%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $24.58
Upside: -26.77%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.06
Upside: +10.84%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.30
Upside: +169.23%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $1.93
Upside: +184.97%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $5.48
Upside: +73.36%